切换至 "中华医学电子期刊资源库"

中华细胞与干细胞杂志(电子版) ›› 2024, Vol. 14 ›› Issue (06) : 328 -335. doi: 10.3877/cma.j.issn.2095-1221.2024.06.002

论著

菝葜皂苷元对肝癌HepG2细胞抑制作用的机制研究
张敏1, 朱建华1, 缪雅芳2, 郭锦荣3,()   
  1. 1.201318 上海,上海健康医学院附属周浦医院普外科
    2.201318 上海,上海健康医学院附属周浦医院呼吸科
    3.201318 上海,上海健康医学院附属周浦医院中医科
  • 收稿日期:2024-06-17 出版日期:2024-12-01
  • 通信作者: 郭锦荣
  • 基金资助:
    上海市浦东新区科技发展基金民生科研专项资金 (PKJ2020-Y105)上海市浦东新区卫生健康委员会中西医协同旗舰医院 (YC-2023-0401)

Inhibitory effect and mechanism of sarsasapogenin on hepatocellular carcinoma HepG2 cells

Min Zhang1, Jianhua Zhu1, Yafang Miao2, Jinrong Guo3,()   

  1. 1.Department of General Surgery, Shanghai University of Medicine & Health Sciences Affiliated Zhoupu Hospital, Shanghai 201318, China
    2.Department of Respiratory Medicine, Shanghai University of Medicine & Health Sciences Affiliated Zhoupu Hospital, Shanghai 201318, China
    3.Department of Traditional Chinese Medicine, Shanghai University of Medicine & Health Sciences Affiliated Zhoupu Hospital, Shanghai 201318, China
  • Received:2024-06-17 Published:2024-12-01
  • Corresponding author: Jinrong Guo
引用本文:

张敏, 朱建华, 缪雅芳, 郭锦荣. 菝葜皂苷元对肝癌HepG2细胞抑制作用的机制研究[J/OL]. 中华细胞与干细胞杂志(电子版), 2024, 14(06): 328-335.

Min Zhang, Jianhua Zhu, Yafang Miao, Jinrong Guo. Inhibitory effect and mechanism of sarsasapogenin on hepatocellular carcinoma HepG2 cells[J/OL]. Chinese Journal of Cell and Stem Cell(Electronic Edition), 2024, 14(06): 328-335.

目的

探讨金刚藤的主要成分菝葜皂苷元 (SAR)对肝癌的抗肿瘤作用及其潜在分子机制。

方法

采用SAR处理人肝癌细胞HepG2;运用CCK-8和EdU染色方法定量评估细胞的增殖活性;流式细胞术分析细胞的凋亡状况;Transwell实验检测细胞的迁移与侵袭能力;通过RNA测序 (RNA-seq)、GO、KEGG和PPI分析差异性表达基因功能、信号通路和蛋白相互作用。两组间比较采用独立样本t检验,多组间比较采用单因素方差分析,组间两两比较采用LSD-t检验。

结果

CCK-8实验显示,HepG2细胞的抑制率随SAR浓度的升高而升高,IC50值为22.5 μg/mL。与对照 (DMSO)比较,SAR处理抑制HepG2细胞的增殖,促进HepG2细胞凋亡,抑制细胞迁移[(40.00 ± 2.00)%比 (80.00 ± 5.00)%]和侵袭[(35.00 ± 2.00)%比 (70.00 ±4.00)%](P 均 < 0.01)。RNA-seq结果表明,SAR处理后,HepG2细胞基因表达发生变化:其中1 308个基因表达上调,2 966个基因表达下调;这些差异表达基因主要富集于细胞增殖和信号受体结合等生物学过程;KEGG分析发现差异表达基因主要富集于类固醇生物合成,补体及凝血级联反应通路,TNF和NF-κB等信号通路。PPI分析显示,CDK3、EPHA7、LRRK2、PRKCB、ANK3、TEK和ZNP70是SAR调控的靶基因。

结论

SAR可降低HepG2细胞的增殖、迁移和侵袭能力,促进其凋亡,其机制可能与TNF信号通路和NF-κB等信号通路相关。

Objective

To investigate the anti-tumor effects of sarsasapogenin (SAR),a major constituent of Smilax china L., on hepatocellular carcinoma and its potential molecular mechanism.

Methods

In this study, HepG2 cells were treated with SAR. Cell proliferation activity was assessed using the CCK-8 assay and EdU staining. Cell apoptosis was determined by flow cytometry. Cell migration and invasion were detected by transwell assay. Dfferential expressed gene functions, signaling pathways, and protein interactions were analyzed through RNA sequencing, GO,KEGG, and PPI analysis. The independent sample t test was used for comparison between two groups,the one-way analysis of variance was used for comparison between multiple groups, and the LSD-t test was used for pairwise comparison between mutiple groups.

Results

The CCK- 8 experiment revealed that SAR treatment significantly inhibited HepG2 cell proliferation with an increase of the concentration, and the IC50 value was 22.5 μg/mL. Compared to control (DMSO), SAR inhibited cell proliferation, increased cell apoptosis level significantly, and led to a significant decrease in cell migration [(40.00 ± 2.00)% vs (80.00 ± 5.00)%]and invasion rates [(35.00 ± 2.00)% vs(70.00 ±4.00)%] (all P < 0.01). RNA-seq showed significant changes in gene expression in HepG2 cells after SAR treatment. 1 308 genes were upregulated, while 2 966 genes were downregulated.The differentially expressed genes were significantly enriched in biological processes such as cell proliferation and signal receptor binding. Further KEGG analysis revealed that the differentially expressed genes mainly enriched in steroid biosynthesis, complement and coagulation cascade,TNF, MAPK, and NF-κB pathway. The hub genes CDK3, EPHA7, LRRK2, PRKCB, ANK3, TEK and ZNP70 were identified as the targets of SAR by PPI network analysis.

Conclusion

SAR could reduce the proliferation, migration and invasion and promote apoptosis of HepG2 cells. The underlying mechanism may involve the TNF signaling pathway, the NF-κB signaling pathway, and other related signaling pathways.

图1 通过CCK-8和EdU实验评估细胞存活率SAR的增殖抑制作用 注:a图为不同浓度SAR孵育48 h细胞存活率;b图为经SAR处理后,CCK-8法检测细胞活力降低,与DMSO比较,aP < 0.05,bP < 0.01;c ~ d图为经SAR处理48 h后,EdU法检测细胞活力降低,与DMSO比较,aP < 0.01
图2 SAR对细胞凋亡产生的影响 注:a图为通过流式细胞术的测定结果显示,经过SAR处理后,细胞的凋亡提升;b图为细胞凋亡比例比较,与DMSO 比较,aP < 0.01
图3 细胞迁移和侵袭的统计结果 注:与DMSO比较,aP < 0.01
图4 SAR对HepG2细胞迁移和侵袭能力的影响 注:左图为0 h、24 h迁移结果,经过SAR处理之后,细胞的迁移率降低 (×200);右图为结晶紫染色结果,SAR处理之后,细胞迁移率和侵袭率降低 (×100)
图5 RNA-seq分析 注:a图为DMSO与SAR的mRNA差异表达比较,紫色代表降低,蓝色代表升高;b图为DMSO与SAR的mRNA差异表达比较,G1代表DMSO,G2代表SAR,蓝色代表 mRNA 表达降低的基因,红色代表 mRNA 表达升高的基因;c图为样本间的相似程度比较,样本距离越近表示样本基因的表达趋势约接近
图6 GO功能富集分析
图7 KEGG通路富集分析
图8 差异表达基因PPI分析
1
Aritomi M, Kawasaki T. A new xanthone C-glucoside, position isomer of mangiferin, from Anemarrhena asphodeloides Bunge[J]. Tetrahedron Lett, 1969, (12):941-944.
2
Attele AS, Zhou YP, Xie JT, et al. Antidiabetic effects of Panax ginseng berry extract and the identification of an effective component[J].Diabetes, 2002, 51(6):1851-1858.
3
Bao W, Pan H, Lu M, et al. The apoptotic effect of sarsasapogenin from Anemarrhena asphodeloides on HepG2 human hepatoma cells[J]. Cell Biol Int, 2007, 31(9):887-892.
4
Chung SY, Kim KJ, Seong J. Biomarkers for locally advanced hepatocellular carcinoma patients treated with liver-directed combined radiotherapy[J]. Liver Cancer, 2022, 11(3):247-255.
5
Forner A, Reig M, Bruix J. Hepatocellular carcinoma[J]. Lancet, 2018,391(10127):1301-1314.
6
Gallicchio R, Nardelli A, Mainenti P, et al. Therapeutic strategies in HCC: radiation modalities[J]. Biomed Res Int, 2016, 2016:1295329.doi: 10.1155/2016/1295329.
7
朱应怀, 胡建平, 李正翔. 金刚藤的现代药学研究及临床应用进展[J]. 海峡药学, 2021, 33(4):42-46.
8
李洁, 唐玉莲, 张美慧. 金刚藤多糖的提取、纯化及抗氧化活性研究[J]. 化学世界, 2021, 62(3):144-148.
9
马廷升, 朱兰翠. 金刚藤的研究进展[J]. 中药材, 2006, 29(10):1114-1116.
10
高满军, 黄兴琼, 莫启贵, 等. 菝葜的化学成分及药用价值研究进展[J]. 湖北科技学院学报(医学版), 2024, 38(4):360-363,368.
11
胡灯. 菝葜的甾体皂苷成分及其抗肿瘤活性研究[D]. 广州:南方医科大学, 2017.
12
段本振, 曲玮, 梁敬钰. 菝葜属植物的化学成分研究进展[J]. 海峡药学, 2013, 25(08):7-13..
13
Keating GM, Santoro A. Sorafenib: a review of its use in advanced hepatocellular carcinoma[J]. Drugs, 2009, 69(2):223-240.
14
Li A, Wu N, Sun J. E2F1-induced microRNA-224-5p expression is associated with hepatocellular carcinoma cell migration, invasion and epithelial-mesenchymal transition via MREG[J]. Oncol Lett, 2022,23(3):82. doi: 10.3892/ol.2022.13202.
15
Chen S, Cheng AC, Wang MS, et al. Detection of apoptosis induced by new type gosling viral enteritis virus in vitro through fluorescein annexin V-FITC/PI double labeling[J]. World J Gastroenterol, 2008,14(14):2174-2178.
16
Justus CR, Marie MA, Sanderlin EJ, et al. Transwell in vitro cell migration and invasion assays[J]. Methods Mol Biol, 2023, 2644:349-359.
17
Kim DW, Talati C, Kim R. Hepatocellular carcinoma (HCC): beyond sorafenib-chemotherapy[J]. J Gastrointest Oncol, 2017, 8(2):256-265.
18
Liu F, Feng XX, Zhu SL, et al. Sonic hedgehog signaling pathway mediates proliferation and migration of fibroblast-like synoviocytes in rheumatoid arthritis via MAPK/ERK signaling pathway[J]. Front Immunol, 2018, 9:2847. doi: 10.3389/fimmu.2018.02847.
19
Ma Y, Wen J, Wang J, et al. Asiaticoside antagonizes proliferation and chemotherapeutic drug resistance in hepatocellular carcinoma(HCC) cells[J]. Med Sci Monit, 2020, 26:e924435. doi: 10.12659/MSM.924435.
20
Rich NE, Singal AG. Overdiagnosis of hepatocellular carcinoma:Prevented by guidelines[J]? Hepatology, 2022, 75(3):740-753.
21
Sun X, Zhang C, Jin H, et al. Flow cytometric analysis of T lymphocyte proliferation in vivo by EdU incorporation[J]. Int Immunopharmacol,2016, 41:56-65.
22
Pressiani T, Boni C, Rimassa L, et al. Sorafenib in patients with Child-Pugh class A and B advanced hepatocellular carcinoma: a prospective feasibility analysis[J]. Ann Oncol, 2013, 24(2):406-411.
23
Que W, Chen M, Yang L, et al. A network pharmacology-based investigation on the bioactive ingredients and molecular mechanisms of gelsemium elegans benth against colorectal cancer[J]. BMC Complement Med Ther, 2021, 21(1):99. doi: 10.1186/s12906-021-03273-7.
24
Song LN, Qiao GL, Yu J, et al. Hsa_circ_0003998 promotes epithelial to mesenchymal transition of hepatocellular carcinoma by sponging miR-143-3p and PCBP1[J]. J Exp Clin Cancer Res, 2020, 39(1):114.doi: 10.1186/s13046-020-01576-0.
25
Su Y, Zhao D, Jin C, et al. Dihydroartemisinin induces ferroptosis in Hcc by promoting the formation of Pebp1/15-Lo[J]. Oxid Med Cell Longev, 2021, 2021:3456725. doi: 10.1155/2021/3456725.
26
Lv B, Zhu W, Feng C. Coptisine blocks secretion of exosomal circCCT3 from cancer-associated fibroblasts to reprogram glucose metabolism in hepatocellular carcinoma[J]. DNA Cell Biol, 2020. doi:10.1089/dna.2020.6058.
27
Zhong C, Zhang YF, Huang JH, et al. The Chinese medicine, Jianpi Huayu Decoction, inhibits the epithelial mesenchymal transition via the regulation of the Smad3/Smad7 cascade[J]. Am J Transl Res, 2017,9(6):2694-2711.
28
诸佳瑜, 陈闯, 欧杰, 等. 中医辩证治疗原发性肝癌的研究进展[J].当代医药论丛, 2017, 15(10):32-34.
29
国家药典委员会. 中华人民共和国药典:2020年版.一部[M]. 北京:中国医药科技出版社, 2020.
30
赵建成, 谢继增, 杨建宇. 肿瘤方剂大辞典[M]. 北京:中医古籍出版社, 2009.
31
倪源. 菝葜皂苷元致肝癌HepG2细胞凋亡作用机理的研究[D]. 杭州:浙江大学, 2008.
32
张锐. 知母菝葜皂苷元的分离纯化以及体外诱导肝癌细胞HepG2凋亡的研究[D]. 杭州:浙江大学, 2006.
33
Lim SM, Jeong JJ, Kang GD, et al. Timosaponin AIII and its metabolite sarsasapogenin ameliorate colitis in mice by inhibiting NF- κB and MAPK activation and restoring Th17/Treg cell balance[J].Int Immunopharmacol, 2015, 25(2):493-503.
34
张弓. EphA7在原发性肝细胞癌中的表达及其体外抑制研究[D].郑州:郑州大学, 2010.
35
莫莉.Cdk3在原发性肝细胞癌中的表达及作用机制[D].长沙:中南大学, 2007.
[1] 樊恒, 孙敏, 朱建华. 红景天苷通过抑制PI3K/AKT/mTOR信号通路对大鼠脓毒症急性肾损伤的保护作用[J/OL]. 中华危重症医学杂志(电子版), 2024, 17(03): 188-195.
[2] 唐丹, 姚晓曦, 杨博文, 薛绍龙, 李梦瑶, 韦柳杏, 郄明蓉. 双肾上腺皮质激素样激酶1对子宫内膜样腺癌患者临床特征的影响[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(05): 582-590.
[3] 白若靖, 郭军. 肺炎克雷伯菌肺炎与干扰素信号通路关系研究进展[J/OL]. 中华实验和临床感染病杂志(电子版), 2024, 18(02): 71-74.
[4] 狄静怿, 陈禹江, 陈欣欣, 陈文霞. 基质细胞衍生因子1通过PI3K/AKT1信号通路对巨噬细胞极化的影响[J/OL]. 中华口腔医学研究杂志(电子版), 2024, 18(02): 89-95.
[5] 李智, 冯芸. NF-κB 与MAPK 信号通路及其潜在治疗靶点在急性呼吸窘迫综合征中的研究进展[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(05): 840-843.
[6] 季加翠, 孙春斌, 罗恩丽. 姜黄素通过调节NF-κB/NLRP3通路减轻LPS诱导小胶质细胞神经炎症损伤[J/OL]. 中华细胞与干细胞杂志(电子版), 2024, 14(04): 193-203.
[7] 李博, 马秀岩, 孙杰. lncRNA TINCR对滋养层HTR-8/SVneo细胞生物学行为的影响及其机制[J/OL]. 中华细胞与干细胞杂志(电子版), 2024, 14(03): 167-172.
[8] 阿卜杜萨拉木·图尔荪麦麦提, 吐尔洪江·吐逊, 温浩. 肝脏缺血-再灌注损伤与cGAS-STING信号通路[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(03): 394-397.
[9] 麦麦提依明·托合提, 柳叶, 张诚, 阿卜杜喀迪尔·牙森, 高峰, 王继超, 吴永刚. PEA3EPHA2在脑胶质母细胞瘤中的表达及在Wnt/β-catenin通路的作用[J/OL]. 中华脑科疾病与康复杂志(电子版), 2024, 14(02): 73-79.
[10] 刘萍, 刘占举, 张萃. 英夫利西单抗治疗克罗恩病的临床疗效及影响因素[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(01): 28-34.
[11] 靳英, 付小霞, 陈美茹, 袁璐, 郝力瑶. CD147调控MAPK信号通路对结肠癌细胞增殖和凋亡的影响及机制研究[J/OL]. 中华临床医师杂志(电子版), 2024, 18(05): 474-480.
[12] 孙琳, 韩萍萍, 张碧琳, 张军霞. 血清WISP1水平与2型糖尿病患者血尿酸升高的相关性[J/OL]. 中华临床医师杂志(电子版), 2024, 18(02): 178-182.
[13] 陈秋怡, 林熙, 刘珍银. 淋巴管畸形分子机制的研究进展[J/OL]. 中华介入放射学电子杂志, 2024, 12(04): 374-379.
[14] 杨麦青, 张云香. 胃癌化疗后浆膜腔大B细胞淋巴瘤一例报道并文献复习[J/OL]. 中华诊断学电子杂志, 2024, 12(03): 183-187.
[15] 姜晓宇, 付迪, 陈雪英, 申程, 甘立军. 胶原在心肌梗死后心脏重构中的研究进展[J/OL]. 中华诊断学电子杂志, 2024, 12(01): 25-30.
阅读次数
全文


摘要